Manufacturing costs loom large for personalized CAR-T cancer meds and their need for speed
admin 9th June 2017 Uncategorised 0Manufacturing quality and costs always play some part in the price of a new drug, but they are the elephant in the room when looking at CAR-T, personalized cancer medications now under development. That is because of the extensive process to genetically code a patient’s T cells to hunt and kill cancer cells, along with the need for speed.
More: Manufacturing costs loom large for personalized CAR-T cancer meds and their need for speed
Source: fierce